SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer - Quaterly Results

28 Oct 2024 Evaluate
A minor change in the total revenue was seen in the September 2024 quarter. The total revenue for the quarter stood at Rs. 5885.90 millions against Rs. 5752.10 millions during year ago period.The Company has registered profit of Rs. 1583.50  millions for the quarter ended September 2024, a growth of 6.30%  over Rs. 1489.60 millions millions achieved in the corresponding quarter of last year.OP of the company witnessed a marginal growth to 2323.20 millions from 2186.80 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5885.90 5752.10 2.33 11514.50 11065.70 4.06 21931.70 24247.60 -9.55
Other Income 430.70 360.70 19.41 849.10 695.30 22.12 1805.10 1010.50 78.63
PBIDT 2323.20 2186.80 6.24 4516.50 3628.50 24.47 8158.10 9099.10 -10.34
Interest 21.00 27.30 -23.08 42.10 56.00 -24.82 154.10 133.90 15.09
PBDT 2302.20 2159.50 6.61 4474.40 3572.50 25.25 8083.50 9295.20 -13.04
Depreciation 149.90 154.30 -2.85 295.90 309.80 -4.49 622.80 1055.10 -40.97
PBT 2152.30 2005.20 7.34 4178.50 3262.70 28.07 7460.70 8240.10 -9.46
TAX 568.80 515.60 10.32 1087.90 837.80 29.85 1947.40 2000.80 -2.67
Deferred Tax -30.10 42.20 -171.33 -61.50 30.10 -304.32 361.10 -519.10 -169.56
PAT 1583.50 1489.60 6.30 3090.60 2424.90 27.45 5513.30 6239.30 -11.64
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 39.47 38.02 3.82 39.22 32.79 19.62 37.20 37.53 -0.87

Pfizer Share Price

4828.35 17.30 (0.36%)
11-May-2026 09:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.10
Dr. Reddys Lab 1279.30
Cipla 1342.10
Zydus Lifesciences 937.00
Lupin 2292.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×